Locsense, StratiCELL and the Radboudumc are proud to announce Eurostars funding supporting the development of a breakthrough Epithelial Sensing solution that accurately measures the barrier function of new in-vitro skin constructs, closely resembling the in-vivo situation.
The platform assesses skin barrier function in a non-intrusive manner for dermo(cosmetic) and pharmaceutical applications. Longitudinal effects of compounds on healthy and challenged skin models can be studied with this innovation. In addition, beneficial effects of cosmetic and dermo cosmetic components on skin barrier function reinforcement can be tested in-vitro.
Radboudumc translates the results from in-vitro skin disease models towards the patient population and studies the biological relevance of skin barrier perturbance on skin health.
Eurostars is part of the European Partnership on Innovative SMEs. The partnership is co-funded by the European Union through Horizon Europe and the national budgets of 37 Eurostars Participating States and Partner Countries. Dutch funding body, the Netherlands Enterprise Agency (RVO), supports SMEs participating in our Eurostars programme.